Why is Procter & Gamble Health Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 7.93% and Operating profit at 16.97% over the last 5 years
2
Stock is technically in a Mildly Bearish range
- Multiple factors for the stock are Bearish like RSI, Bollinger Band and KST
3
With ROE of 54.1, it has a Very Expensive valuation with a 14.1 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -4.98%, its profits have risen by 16.1% ; the PEG ratio of the company is 1.6
- At the current price, the company has a high dividend yield of 3.7
4
Below par performance in long term as well as near term
- Along with generating -4.98% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is P & G Health Ltd for you?
Medium Risk, Medium Return
Absolute
Risk Adjusted
Volatility
P & G Health Ltd
-4.98%
-0.17
29.45%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
7.93%
EBIT Growth (5y)
16.97%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.49
Sales to Capital Employed (avg)
1.96
Tax Ratio
27.12%
Dividend Payout Ratio
88.52%
Pledged Shares
0
Institutional Holding
19.06%
ROCE (avg)
99.97%
ROE (avg)
42.05%
Valuation Key Factors 
Factor
Value
P/E Ratio
26
Industry P/E
40
Price to Book Value
14.13
EV to EBIT
18.95
EV to EBITDA
18.03
EV to Capital Employed
26.70
EV to Sales
6.02
PEG Ratio
1.62
Dividend Yield
3.66%
ROCE (Latest)
140.93%
ROE (Latest)
54.13%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Movement
11What is working for the Company
CASH AND CASH EQUIVALENTS(HY)
Highest at Rs 329.04 cr
NET SALES(Q)
Highest at Rs 382.49 cr
PBDIT(Q)
Highest at Rs 152.37 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 39.84%
PBT LESS OI(Q)
Highest at Rs 146.16 cr.
PAT(Q)
Highest at Rs 111.51 cr.
EPS(Q)
Highest at Rs 67.17
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for P & G Health Ltd
Net Sales - Quarterly
Highest at Rs 382.49 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 152.37 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 39.84%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 146.16 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 146.16 cr has Grown at 28.13%
Year on Year (YoY)MOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 111.51 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 111.51 cr has Grown at 25.9%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 67.17
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Cash and Cash Equivalents - Half Yearly
Highest at Rs 329.04 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents